Calcium acetate

醋酸钙

Report date: 2023/02/21 20:00:25
NME

Base Information

Drug NameCalcium acetate
Drug Alias NameAcetate of Lime乙酸钙Calcio, acetato deKalsiumasetaattiKalsiyum Asetat +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHealthy AgingHyperphosphatemiaHypocalcemia +[5] 
Global Approved IndicationsHyperphosphatemiaHypocalcemia
Approved Indications in ChinaHyperphosphatemiaHypocalcemia
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesFresenius Kabi Ag
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado DenverKunming Bangyu Pharmaceutical Co Ltd
Inactive CompaniesFresenius Medical Care North AmericaNabi Biopharmaceuticals
Active IndicationsHealthy AgingHyperphosphatemiaHypocalcemia
Inactive IndicationsKidney Failure, ChronicRenal Insufficiency

Other Information

ATC CodeV03AE07
Related LinksWikipediaDrugBankKEGG